Rigel Pharmaceuticals, Inc.
_________________________________________________________________________________
Rigel Pharmaceuticals, Inc. Financial Snapshot
Operating Performance
Fast Facts
1180 Veterans Blvd., South San Francisco, The company reported revenues of US$125.00 million
Headquarters Address
94080,United States of America during 2010, with a CAGR of 39.01% during 2006–
2010. Its revenue grew at an annual rate of
Telephone + 1 650 6241100
16566.67% over the previous fiscal year. In 2010, the
company recorded an operating margin of 28.25%, as
Fax + 1 650 6241101 against -14938.27% in 2009.
Website www.rigel.com
Revenue and Margins
Ticker Symbol, Stock Exchange RIGL, NASDAQ
Number of Employees 145
Fiscal Year End December
Revenue (in US$ million) 125.00
SWOT Analysis
Strengths Weaknesses
Focus on R&D activities Lack of manufacturing facilities
Strategic collaborations Overdependence on single customer
Strong top-line performance
Opportunities Threats
Changing demographics Competitive environment
Growing prevalence of cancer Outcome of clinical trials
Tightening of the FDA’s regulatory
Increasing of healthcare expenditure
oversight
___________________________________________________________________________________________
Rigel Pharmaceuticals, Inc. - SWOT Profile Page 1
Rigel Pharmaceuticals, Inc.
_________________________________________________________________________________
TABLE OF CONTENTS
1 Business Analysis ................................................................................................................................... 5
1.1 Company Overview ................................................................................................................................................5
1.2 Business Description ..............................................................................................................................................5
1.3 Major Products and Services .................................................................................................................................6
2 Analysis of Key Performance Indicators ............................................................................................... 7
2.1 Five Year Snapshot: Overview of Financial and Operational Performance Indicators ..........................................7
2.2 Key Financial Performance Indicators .................................................................................................................10
2.2.1 Revenue and Operating Profit .........................................................................................................................10
2.2.2 Asset, Liabilities and Capex .............................................................................................................................11
2.2.3 Solvency ..........................................................................................................................................................12
2.2.4 Valuation ..........................................................................................................................................................13
2.3 Key Competitors ...................................................................................................................................................14
3 Mergers & Acquisitions and Partnerships ........................................................................................... 15
3.1 M&A and Partnerships Strategy ...........................................................................................................................15
4 Recent Developments ........................................................................................................................... 18
5 SWOT Analysis ...................................................................................................................................... 20
5.1 SWOT Analysis - Overview ..................................................................................................................................20
5.2 Strengths ..............................................................................................................................................................20
5.3 Weaknesses .........................................................................................................................................................20
5.4 Opportunities ........................................................................................................................................................21
5.5 Threats .................................................................................................................................................................21
6 Rigel Pharmaceuticals, Inc. - Company Statement ............................................................................. 23
7 History .................................................................................................................................................... 25
8 Rigel Pharmaceuticals, Inc. - Key Employees ..................................................................................... 26
9 Key Employee Biographies................................................................................................................... 27
10 Appendix ................................................................................................................................................ 28
10.1 Methodology .........................................................................................................................................................28
10.2 Ratio Definitions ...................................................................................................................................................28
10.3 Disclaimer.............................................................................................................................................................32
___________________________________________________________________________________________
Rigel Pharmaceuticals, Inc. - SWOT Profile Page 2
Rigel Pharmaceuticals, Inc.
__________________________________________________________________________________________
List of Tables
Table 1: Major Products and Services ..................................................................................................................................6
Table 2: Key Ratios - Annual ..................................................................................................................................................7
Table 3: Key Ratios - Interim ..................................................................................................................................................9
Table 4: Key Capital Market Indicators ..................................................................................................................................9
Table 5: Rigel Pharmaceuticals, Inc., History .......................................................................................................................25
Table 6: Rigel Pharmaceuticals, Inc., Key Employees .........................................................................................................26
Table 7: Key Employee Biographies ....................................................................................................................................27
___________________________________________________________________________________________
Rigel Pharmaceuticals, Inc. - SWOT Profile Page 3
Rigel Pharmaceuticals, Inc.
__________________________________________________________________________________________
List of Figures
Figure 1: Revenue and Operating Profit ..................................